Personalized medicine for effective Alzheimer disease treatment

JAMA Neurology

Volumn 72, Issue 5, 2015, Pages 497-498

  Kosik, Kenneth S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CD2 ASSOCIATED PROTEIN; CD33 ANTIGEN; CELF1 PROTEIN; EPHRIN RECEPTOR A1; HLA DRB5 ANTIGEN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2;

ABCA7 GENE; ALZHEIMER DISEASE; APOE4 GENE; BIN1 GENE; CASS4 GENE; CD2AP GENE; CD33 GENE; CELF1 GENE; CLU GENE; CR1 GENE; DSG2 GENE; EPHA1 GENE; FERMT2 GENE; GENE; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; HLA DBR1 GENE; HLA DRB5 GENE; HUMAN; INDIVIDUALIZATION; INPP5D GENE; MEF2C GENE; MS4A GENE; NME8 GENE; NOTE; PERSONALIZED MEDICINE; PICALM GENE; PLD3 GENE; PRIORITY JOURNAL; PTK2B GENE; RISK ASSESSMENT; SLC24H4 RIN3 GENE; SORL1 GENE; TREM2 GENE; ZCWPW1 GENE; GENETICS; METABOLISM; PROCEDURES; STANDARDS;

ALZHEIMER DISEASE; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84938510452     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.3445     Document Type: Note

References (7)

1. Reiman EM, Langbaum JB, Fleisher AS, et al. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis. 2011;26(suppl 3):321-329.
2. Karch CM, Goate AM. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77(1):43-51.
3. Mapstone M, Cheema AK, Fiandaca MS, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20(4):415-418.
4. Weinstein G, Wolf PA, Beiser AS, Au R, Seshadri S. Risk estimations, risk factors, and genetic variants associated with Alzheimer's disease in selected publications from the Framingham Heart Study. J Alzheimers Dis. 2013;33(suppl 1):S439-S445.
5. Hye A, Riddoch-Contreras J, Baird AL, et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. 2014;10(6):799-807.e2.
6. Sanders DW, Kaufman SK, DeVos SL, et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. 2014;82(6):1271-1288.
7. Lo AW, Ho C, Cummings J, Kosik KS. Parallel discovery of Alzheimer's therapeutics. Sci Transl Med. 2014;6(241):241cm5.